Within the class S4 of hormone and metabolic modulators of the WADA Prohibited List, 39% of the adverse analytical findings (AAF) reported in 2020 resulted from SERMs (tamoxifen and clomiphene) and another 29% from AIs (letrozole, anastrozole, exemestane, and adrostatrienedione) ( Among the other PCT drugs, bromocriptine, which is similar to the popular cabergoline, an ergot alkaloid derivative used to treat hyperprolactinemia, is less common than cabergoline among AAS users during PCT owing to its many side effects, such as low blood pressure, dizziness, confusion, and nausea
Eur J Clin Invest 27: 257267
This can affect how well we absorb important nutrients
Novo Nordisks Cagrilintide and the potential combination therapies with Semaglutide, often referred to as CagriSema, are leading examples of this strategy